To evaluate the Safety and medicinal effectiveness of Unani formulations Habb e Tursh Mushtahi in Zof al-IshtihÄ? (Anorexia)

Clinical Validation of Unani Pharmacopoeial formulation Habb e Tursh Mushtahi in Zof al-IshtihÄ? (Anorexia)

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2015/10/006274

Enrollment

300

Registered

2015-10-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R630- Anorexia Health Condition 2: null- Zof al-IshtihÄ? (Anorexia)

Interventions

Intervention1: Habb e Tursh Mushtahi: 5 gms orally twice daily before meals with water for 2 weeks Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: • Patients of either sex in the age group of 18-65 • Decreased Appetite with SNAQ

Exclusion criteria

Exclusion criteria: • Patients having Anorexia Nervosa • Patients with disorders requiring long term treatment • Known cases of Hepatic, Renal or Cardiac Ailments • History of Addictions (Alcohol,Drugs) • Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
improvement in the sign and symptoms of Zof al-IshtihÄ? (Anorexia)Timepoint: 2 weeks	—

Secondary

Measure	Time frame
Hematological and biochemical assessments for safetyTimepoint: 2 weeks	—

Countries

India

Contacts

Public ContactDR PRADEEP KUMAR

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@gmail.com9810161758

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026